Summary
For Year 2026-27, Onyx Biotec reports the following shareholding: Total Promoters at 65.1%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 1.07%, Domestic Institutional Investors at 2.39%, and Retail at 31.44%. This breakdown provides a quick snapshot of ownership distribution for Onyx Biotec in 2026-27.
Onyx Biotec FAQs
As of 04-2026, the promoter shareholding in Onyx Biotec stands at 65.1% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Onyx Biotec is 1.07% and 2.39% respectively.
The retail shareholding of the Onyx Biotec is 31.44%.
Changes in shareholding patterns of Onyx Biotec can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Onyx Biotec are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
